Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
NCT07054684

Study of BHV-1400 in IgA Nephropathy

Led by Biohaven Therapeutics Ltd. · Updated on 2026-03-10

20

Participants Needed

12

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).

CONDITIONS

Official Title

Study of BHV-1400 in IgA Nephropathy

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have biopsy-confirmed IgA Nephropathy
  • Age between 18 and 65 years
Not Eligible

You will not qualify if you...

  • Any secondary IgA Nephropathy
  • Any cause of chronic kidney disease not diagnosed as IgA Nephropathy or due to a non-IgA Nephropathy cause

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

Site-001

Farmington, Connecticut, United States, 06030

Actively Recruiting

2

Site-003

Miami Lakes, Florida, United States, 33016

Actively Recruiting

3

Site-011

Miami Lakes, Florida, United States, 33172

Actively Recruiting

4

Site-013

Orlando, Florida, United States, 32806

Actively Recruiting

5

Site-005

Pembroke Pines, Florida, United States, 33029

Actively Recruiting

6

Site-008

Lawrenceville, Georgia, United States, 30046

Actively Recruiting

7

Site-009

Hinsdale, Illinois, United States, 60521

Actively Recruiting

8

Site-012

Indianapolis, Indiana, United States, 46268

Actively Recruiting

9

Site-006

Chesterfield, Missouri, United States, 63017

Actively Recruiting

10

Site-002

Dakota Dunes, South Dakota, United States, 57049

Actively Recruiting

11

Site-004

Houston, Texas, United States, 77099

Actively Recruiting

12

Site-007

Leicester, United Kingdom, LE5 4PW

Actively Recruiting

Loading map...

Research Team

C

Chief Medical Officer

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here